XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen ...

Fortress Biotech, Inc. ("Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to ...

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue ...

2:00 p.m. – 2:30 p.m. ET: Fireside Chat 5:00 p.m. – 6:00 p.m. ET: Panel Presentation: Development Stage Companies – Where Do Royalty and Tech Platform Plays Fit? To register for the ...

24, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing ... in a fireside chat at the virtual Lytham Partners Fall 2024 Investor ...

The company has so far built a “compelling body ... XLRP patients improve their ability to visually navigate through a virtual maze in the phase 3 Lumeos trial. Although the study did make ...

and members of management will participate in one-on-one meetings at the BTIG Virtual Biotechnology Conference being held August 5-6, 2024. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

Omada Health filed for an IPO on Friday, the latest digital health company to announce its intent to test the public market.